Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-037251

Options or other derivatives

  • Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Harris Peter · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2006-06-14 Grant or award : show line 1 in the form Option to Purchase Common Stock +100,000 100,000 D
Loading xslF345X02/rrd121356.xml…